ArticleScientific reports2017

BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis.

Adriana Carino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.